COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN IN SPANISH PATIENTS AT MODERATE, HIGH, AND VERY HIGH CARDIOVASCULAR RISK

被引：0
|
作者：
Garcia-Goni, M. [1 ]
Facila, L. [2 ]
Cinza, S. [3 ]
Pinto, X. [4 ]
Cortes, X. [5 ]
Prades, M. [6 ]
Aceituno, S. [6 ]
机构：
[1] Univ Complutense, Madrid, Spain
[2] Hosp Gen Univ Valencia, Valencia, Spain
[3] Porto Do Son Primary Care Hlth Ctr, La Coruna, Spain
[4] Hosp Bellvitge Princeps Espanya, Lhospitalet De Llobregat, Spain
[5] Almirall SA, Barcelona, Spain
[6] Outcomes 10, Castellon De La Plana, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.620
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV74
引用
收藏
页码：S104 / S105
页数：3
相关论文
共 50 条
  • [31] THE EFFECTIVENESS OF ROSUVASTATIN IN HIGH RISK PATIENTS TREATMENT
    Kuznetsova, T.
    Gavrilov, D.
    Kirillova, A.
    Dudanov, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 221 - 222
  • [32] Cost-effectiveness analysis of a cardio-oncology rehabilitation framework compared to an exercise intervention for cancer survivors with high cardiovascular risk
    Viamonte, Sofia G.
    Tavares, Aida
    Alves, Alberto J.
    Joaquim, Ana
    Vilela, Eduardo
    Capela, Andreia
    Costa, Ana Joao
    Duarte, Barbara
    Rato, Nuno Dias
    Afreixo, Vera
    Carvalho, Ricardo Fontes
    Santos, Mario
    Ribeiro, Fernando
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024,
  • [33] Screening for second primary melanoma in high risk patients: A cost-effectiveness analysis
    Seth, Divya
    Krasne, Margaret
    James, Lyndon
    Kim, Jane
    Bordeaux, Jeremy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB2 - AB2
  • [34] Analysis of Effectiveness and Safety of Romosozumab in Patients with Very High Risk of Fracture in a Spanish Population
    Moreno Garcia, Marina Soledad
    Gonzalez Mazario, Roxana
    Uson Rodriguez, Yedra
    Merino Ibarra, Erardo
    Giner, Emilio
    Cobeta Garcia, Juan Carlos
    Arce Benavente, Marilia
    Fabregas Canales, Maria Dolores
    Ullier Bellmunt, Julia
    Boselli, Giuliano
    Martinez Valles, Pilar
    Fragio Gil, Jorge Juan
    Vazquez Galeano, Carlos
    Turrion Nieves, Ana
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4326 - 4328
  • [35] Effects of atorvastatin and rosuvastatin on renal function in patients at high cardiovascular risk: a meta-analysis of 21 randomized trials
    Savarese, G.
    Volpe, M.
    Musella, F.
    Casaretti, L.
    Perrone-Filardi, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 950 - 950
  • [36] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT HIGH CARDIOVASCULAR RISK IN POLAND
    Pawlik, D.
    Wojcik, R.
    Zawodnik, A.
    Kaczor, M. P.
    VALUE IN HEALTH, 2017, 20 (09) : A478 - A478
  • [37] Rosuvastatin is more cost-effective compared to atorvastatin and simvastatin for hyperlipidemia management in high-risk patients in routine clinical practice
    Ohsfeldt, RL
    Gandhi, SK
    Fox, KM
    Stacy, T
    McKenney, JM
    VALUE IN HEALTH, 2006, 9 (03) : A123 - A123
  • [38] COST-EFFECTIVENESS OF ALIROCUMAB FOR PATIENTS WITH HYPERCHOLESTEROLEMIA AT HIGH CV RISK
    Yang, M. C.
    Tan, E. C. H.
    VALUE IN HEALTH, 2019, 22 : S128 - S128
  • [39] The cost-effectiveness of preoperative optimisation of high risk surgical patients
    AN Chamberlain
    N Harper
    S Morris
    Critical Care, 6 (Suppl 1):
  • [40] THE COST-EFFECTIVENESS OF TAVI IN INOPERABLE AND HIGH RISK PATIENTS IN FRANCE
    Goodall, G.
    Zemanova, B.
    Candolfi, P.
    Sohlberg, A.
    VALUE IN HEALTH, 2017, 20 (09) : A589 - A589
12345